Medical Advisory Panel

 

The Medical Advisory Panel advises the MRA leadership team on medical matters and policies including medical consultations, clinical research needs and opportunities, clinical regulatory and policy initiatives, and public education about melanoma.

Membership 2011-2015

 

 

Dermatology

 

David Fisher, M.D., Ph.D

Chief, Department of Dermatology
Director, Melanoma Program, MGH Cancer Center
Director, Cutaneous Biology Research Center
Massachusetts General Hospital 
Edward Wigglesworth Professor of Dermatology
Harvard Medical School
 back to top 

 

Sancy Leachman, M.D., Ph.D.

Director, Melanoma and Cutaneous Oncology Program, Huntsman Cancer Institute
Professor, Department of Dermatology, University of Utah

 back to top

 

Roger Lo, M.D., Ph.D.

Director, Melanoma Clinic in Dermatology
Assistant Clinical Professor of Medicine, Dermatology
University of California, Los Angeles 
 back to top

 

David Polsky, M.D., Ph.D.

Associate Professor of Dermatology and Pathology
Director, Pigmented Lesion Section 
NYU Langone Medical Center
Joan and Joel Smilow Research Center

 back to top

 

Susan M. Swetter, M.D.

Professor of Dermatology
Director, Pigmented Lesion & Melanoma Program
Stanford University Medical Center and Cancer Institute

Susan M. Swetter, MD, is Professor of Dermatology and Director of the Pigmented Lesion and Melanoma Program at Stanford University Medical Center and Cancer Institute. Dr Swetter received her BA with Distinction from the University of Virginia and her MD from the University of Pennsylvania School of Medicine. She completed an internship in internal medicine at University of California San Francisco, followed by a residency and a chief residency in dermatology at Stanford University Medical Center. She joined the Stanford Dermatology faculty in 1994 and has directed the Pigmented Lesion and Melanoma Programs at Stanford and VA Palo Alto since 1995. Dr. Swetter’s research interests include primary and secondary prevention strategies in melanoma and clinical studies of melanoma epidemiology, prognostic factors, and chemoprevention. She serves on the National Comprehensive Cancer Network Melanoma Panel and on the American Academy of Dermatology melanoma practice guidelines task force. She is the national dermatologist liaison to the Eastern Cooperative Oncology Group’s Melanoma Committee and co-directs the Melanoma Prevention Working Group, a multi-center Intergroup collaboration dedicated to cancer control and melanoma prevention.

 back to top

 

Medical Oncology

 

Paul Chapman, M.D. - Chair

Attending Physician, Melanoma / Sarcoma service, Memorial Sloan-Kettering Cancer Center
Professor of Medicine, Weill Medical College of Cornell University
 back to top 

 

Thomas Gajewski, M.D., Ph.D.

Professor, Departments of Pathology and Medicine
University of Chicago 
 back to top 

 

F. Stephen Hodi, M.D.

Assistant Professor, Department of Medicine, Harvard Medical School
Assistant Professor of Medicine, Dana-Farber Cancer Institute 
 back to top 

 

Patrick Hwu, M.D.

Department Chair, Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Dr. Patrick Hwu is considered one of the leading tumor immunologists in the country, and a primary force in the development of novel vaccine and adoptive T-cell therapies. His laboratory and clinical work have led to insights and advances in the understanding of the interactions between tumors and the immune system, and the development of cellular immunotherapies. He was recruited to be the first Chairman of the Department of Melanoma Medical Oncology in 2003. Since that time, he has also served as Associate Director of the Center for Cancer Immunology Research and is the current Chair of MD Anderson Cancer Center’s Promotion and Tenure Committee. His laboratory is significantly funded by the National Cancer Institutes. He is the principal investigator on three RO1 translational immunotherapy grants, as well as a P01 comprehensive program grant that is investigating the use of plasmacytoid dendritic cells to enhance immunotherapy. Dr. Hwu is a member of the editorial board of the Journal of Immunotherapy. He is a frequently requested national and international lecturer. He has published more than 90 peer-reviewed articles. Dr. Hwu is the recipient of numerous awards such as the George and Barbara Bush Endowment for Innovative Cancer Research in 2004, the Robert R. Herring Professorship in Clinical Research 2004 – 2007, the Moshe Talpaz Endowed Chair in Immunology from 2007 to present, and the Division of Cancer Medicine Hematology/Oncology Fellowship Program Mentor of the Year for FY2009, just to name a few.
 back to top 

 

Patricia LoRusso, D.O.

Professor of Medicine, Associate Director of Innovative Medicine, Yale Cancer Center
 back to top

 

Kim Margolin, M.D.

Professor, Department of Medicine
University of Washington / Seattle Cancer Center 
 back to top

 

Antoni Ribas, M.D., Ph.D.

Professor of Medicine
University of California, Los Angeles 
 back to top

 

Lynn Schuchter, M.D.

C. Willard Robinson Professor of Hematology-Oncology
Attending Physician, Hospital of the University of Pennsylvania
Program Leader: Melanoma Program,
Abramson Cancer Center of the University of Pennsylvania
Division Chief, Hematology-Oncology, University of Pennsylvania
 back to top

 

Jedd Wolchok, M.D., Ph.D

Associate Professor
Memorial Sloan-Kettering Cancer Center
 back to top

 

Surgical Oncology

 

Jeffrey Gershenwald, M.D.

Professor, University of Texas, M.D. Anderson Cancer Center
 back to top

 

Suzanne Topalian, M.D.

Professor of Surgery and Oncology, Johns Hopkins University School of Medicine
Director, Melanoma Program, Sidney Kimmel Comprehensive Cancer Center
 back to top

 

Jeffrey S. Weber, M.D., Ph.D.

Director of the Donald A. Adam Comprehensive Melanoma Research Center at the Moffitt Cancer Center
 back to top